These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21104921)

  • 1. Proteomic profiling of chordoma.
    DeLaney TF; Duan Z; Hornicek FJ
    J Surg Oncol; 2010 Dec; 102(7):719. PubMed ID: 21104921
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential proteomic profiling of chordomas and analysis of prognostic factors.
    Zhou H; Chen CB; Lan J; Liu C; Liu XG; Jiang L; Wei F; Ma QJ; Dang GT; Liu ZJ
    J Surg Oncol; 2010 Dec; 102(7):720-7. PubMed ID: 20721957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of cancer--opportunities, challenges, and context.
    Arnott D; Emmert-Buck MR
    J Pathol; 2010 Sep; 222(1):16-20. PubMed ID: 20623483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cancer proteomics.
    Hu S; Wong DT
    Curr Opin Mol Ther; 2007 Oct; 9(5):467-76. PubMed ID: 17932810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
    Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
    Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in oncoproteomics.
    Jain KK
    Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomic and transcriptomic profiling of the human hepatocellular carcinoma.
    Minagawa H; Honda M; Miyazaki K; Tabuse Y; Teramoto R; Yamashita T; Nishino R; Takatori H; Ueda T; Kamijo K; Kaneko S
    Biochem Biophys Res Commun; 2008 Feb; 366(1):186-92. PubMed ID: 18060859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicobiochemical study of diagnostic value of the panel including 10 potential protein markers of prostatic cancer].
    Shishkin SS; Dzeranov NK; Totrov KI; Kazachenko AV; Kovaleva MA; Toropygin IIu
    Urologiia; 2009; (1):56-8. PubMed ID: 19432234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome analysis in the study of lymphoma cells.
    Joubert-Caron R; Caron M
    Mass Spectrom Rev; 2005; 24(4):455-68. PubMed ID: 15389845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer proteomics: from biomarker discovery to signal pathway profiling.
    Bichsel VE; Liotta LA; Petricoin EF
    Cancer J; 2001; 7(1):69-78. PubMed ID: 11269650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of proteomics to diagnosis and treatment of lung cancer].
    Dai M; Luo RC
    Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression proteomics of human colon cancer.
    Mazzanti R; Solazzo M; Fantappié O; Elfering S; Pantaleo P; Bechi P; Cianchi F; Ettl A; Giulivi C
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1329-38. PubMed ID: 16439467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics: present and future implications in neuro-oncology.
    Micallef J; Gajadhar A; Wiley J; DeSouza LV; Michael Siu KW; Guha A
    Neurosurgery; 2008 Mar; 62(3):539-55; discussion 539-55. PubMed ID: 18425004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative proteomics analysis of human pituitary adenomas: current status and future perspectives.
    Zhan X; Desiderio DM
    Mass Spectrom Rev; 2005; 24(6):783-813. PubMed ID: 15495141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.